We are live on ! Find out more
PTC

Philadelphia Trust Company Portfolio holdings

AUM $1.42B
1-Year Est. Return 43.77%
This Fund
S&P 500
This Quarter Est. Return
+11.93%
1 Year Est. Return
+43.77%
3 Year Est. Return
+141.5%
5 Year Est. Return
+176.17%
10 Year Est. Return
+554.31%
AUM
$1.13B
AUM Growth
+$197M
Cap. Flow
+$32.7M
Cap. Flow %
2.88%
Top 10 Hldgs %
29.71%
Holding
207
New
31
Increased
81
Reduced
51
Closed
7

Top Buys

Rank Stock Value
1
INTC icon
Intel
INTC
+$13.7M
2
MDT icon
Medtronic
MDT
+$11.2M
3
TER icon
Teradyne
TER
+$8.87M
4
KSS icon
Kohl's
KSS
+$7.5M
5
ROK icon
Rockwell Automation
ROK
+$6.74M

Sector Composition

Rank Sector Weight
1 Technology 21.45%
2 Financials 17.16%
3 Healthcare 15.07%
4 Communication Services 11.69%
5 Industrials 9.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.93T
$42.9M 3.79%
364,093
+10,499
+3% +$1.15M
ABT icon
2
Abbott
ABT
$191B
$39.1M 3.45%
488,947
-54,718
-10% -$4.07M
GOOGL icon
3
Alphabet (Google) Class A
GOOGL
$4.07T
$38M 3.35%
645,540
+40,500
+7% +$2.29M
AAPL icon
4
Apple
AAPL
$5.01T
$37.8M 3.33%
795,748
+5,540
+0.7% +$235K
VZ icon
5
Verizon
VZ
$201B
$33.5M 2.95%
566,274
+8,007
+1% +$453K
BRK.B icon
6
Berkshire Hathaway Class B
BRK.B
$1.1T
$32.2M 2.84%
160,053
-597
-0.4% -$121K
LLL
7
DELISTED
L3 Technologies, Inc.
LLL
$29.9M 2.64%
144,978
-400
-0.3% -$79.2K
DD icon
8
DuPont de Nemours
DD
$18.4B
$29.6M 2.61%
219,486
+4,660
+2% +$647K
BAC icon
9
Bank of America
BAC
$431B
$28M 2.47%
1,016,275
+65,460
+7% +$1.85M
META icon
10
Meta Platforms (Facebook)
META
$1.49T
$25.8M 2.28%
154,940
+147
+0.1% +$23.4K
MDT icon
11
Medtronic
MDT
$113B
$25.6M 2.26%
281,486
+124,705
+80% +$11.2M
INTC icon
12
Intel
INTC
$417B
$23.9M 2.11%
445,715
+270,140
+154% +$13.7M
IQV icon
13
IQVIA
IQV
$40.4B
$21.4M 1.89%
148,558
+1,462
+1% +$195K
C icon
14
Citigroup
C
$215B
$20.7M 1.83%
333,124
+17,811
+6% +$1.11M
PG icon
15
Procter & Gamble
PG
$338B
$20.7M 1.83%
198,968
-48,620
-20% -$4.73M
RTN
16
DELISTED
Raytheon Company
RTN
$20.6M 1.82%
113,196
+1,054
+0.9% +$184K
ABB
17
DELISTED
ABB Ltd
ABB
$19.8M 1.75%
1,050,071
+2,701
+0.3% +$52.3K
BIIB icon
18
Biogen
BIIB
$31.5B
$19.2M 1.7%
81,414
+6,634
+9% +$2.09M
MCHP icon
19
Microchip Technology
MCHP
$39.1B
$19.2M 1.69%
462,006
+22,722
+5% +$942K
CVS icon
20
CVS Health
CVS
$138B
$17.9M 1.58%
332,692
+87,649
+36% +$5.41M
PARA
21
DELISTED
Paramount Global Class B
PARA
$17.7M 1.56%
371,733
+16,454
+5% +$802K
NVDA icon
22
NVIDIA
NVDA
$4.64T
$16.6M 1.47%
3,704,200
+709,800
+24% +$2.75M
DUK icon
23
Duke Energy
DUK
$101B
$16.6M 1.46%
183,936
+35,986
+24% +$3.17M
RPM icon
24
RPM International
RPM
$13.9B
$15.8M 1.4%
272,990
+109,223
+67% +$6.2M
CIT
25
DELISTED
CIT Group Inc.
CIT
$15.2M 1.34%
316,743
-10,225
-3% -$481K

Similar funds

Philadelphia Trust Company's Q1 2019 Portfolio in Review

As of Q1 2019, Philadelphia Trust Company held 207 positions worth $1.13B, up 21% from $936M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Philadelphia Trust Company's Q1 2019 filing shows 31 new, 81 increased, 51 reduced and 7 closed positions. Its largest new stake was Teradyne: 237,280 shares worth $9.45M. The largest sale was REGENERX BIOPHARMACEUTICALS, an estimated $60.9M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Philadelphia Trust Company's largest Q1 2019 buy was Teradyne: 237,280 shares worth $9.45M.
  • Philadelphia Trust Company added most to Intel in Q1 2019, an estimated $13.7M increase.
  • Philadelphia Trust Company's biggest Q1 2019 reduction was REGENERX BIOPHARMACEUTICALS, cutting an estimated $60.9M.
  • Philadelphia Trust Company fully exited Huntsman Corp in Q1 2019, selling an estimated $4.92M.
  • Philadelphia Trust Company's ten largest holdings make up 30% of its $1.13B portfolio in Q1 2019.
  • Philadelphia Trust Company opened 31 new positions and closed 7 in Q1 2019.
  • Philadelphia Trust Company's portfolio value rose 21% quarter-over-quarter to $1.13B.

Based on Philadelphia Trust Company's 13F filing for Q1 2019, filed 15 May 2019.